On 13 August 2024, Julia Charlton presented a webinar on Listing Biotech Companies on the Hong Kong Stock Exchange.

This webinar covers the following topics: − Introduction to the HKEx regime for listing pre-revenue Biotech Companies − Chapter 18A suitability requirement under the Guide for New Listing Applicants − Other eligibility requirements for Chapter 18A listings − Requirements for the IPO relating to subscriptions − Listing document disclosure requirements − Continuing obligations of Chapter 18A issuers and requirements relating to changes to listed Biotech Companies

#BiotechIPO on #HKEX for #PreRevenueBiotech companies

Timecodes: 00:00 Introduction to the Biotech Industry and Market Dynamics 01:44 Hong Kong Stock Exchange's Biotech Listing Regime 03:30 Performance and Trends in Biotech Listings 05:25 International Biotech IPO Trends 07:08 Chapter 18A of the Main Board Listing Rules 08:54 Eligibility and Suitability for Listing 13:57 Compliance with Core Product Requirements 17:29 Third-Party Investment and Financial Requirements 25:41 Enhanced Eligibility Requirements 29:29 Public Float and Share Allocation Rules 33:01 Disclosure Requirements for Listing Documents 41:45 Financial Reporting and Regulatory Compliance 50:20 Restrictions and Regulatory Oversight 53:37 Delisting Provisions and Transition to Regular Listing

Charltons Law Firm: https://www.charltonslaw.com/

Julia Charlton https://www.charltonslaw.com/the-firm/people-culture/team-profile/julia-charlton/

Don’t forget to follow our social media: LinkedIn: https://linkedin.com/company/2995759/ Facebook: https://facebook.com/charltons Instagram: https://instagram.com/charltonslaw/ Youtube: https://www.youtube.com/@charltons-law Rumble: https://rumble.com/c/c-1647355